NEW JERSEY (WABC) -- While the push is on to get more of the COVID-19 vaccine, there is some hope on the horizon. Johnson & Johnson is getting closer to seeking emergency FDA approval for its vaccine ...
A top doctor is pushing back against a panel of experts' decision to delay voting on a recommendation to give to the Centers for Disease Control and Prevention regarding the Johnson & Johnson COVID-19 ...
The FDA gave an emergency use authorization of a one-shot coronavirus vaccine by Johnson & Johnson on Saturday, marking the third coronavirus shot allowed to be administered to Americans. Johnson and ...
Johnson & Johnson said Thursday that new data shows that its single-shot COVID-19 vaccine provides protection against the virus for at least eight months and effectively prevents infection from ...
Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
NEW YORK -- Although vaccination sites are pausing Johnson & Johnson vaccine due potentially dangerous blood clots, one doctor is saying this "blip" shouldn't stop people from getting vaccinated.
A healthcare worker fills a syringe from a vial with a dose of the Johnson & Johnson vaccine (Photo by Phill Magakoe / AFP) (Photo by PHILL MAGAKOE/AFP via Getty Images) Studies indicate that the ...
Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants was taken ill. The 60,000-patient clinical trial met the criteria for a “pausing rule,” reported Stat News, ...
NEW YORK CITY (WABC) -- The single-dose Johnson & Johnson vaccine is expected to arrive over the next few days, and deployment should begin almost immediately. The vaccine started shipping from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results